• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Enact Holdings Inc.

    6/4/25 4:13:15 PM ET
    $ACT
    Specialty Insurers
    Finance
    Get the next $ACT alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001227758
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Enact Holdings, Inc.
    SEC File Number
    001-40399
    Address of Issuer
    8325 SIX FORKS ROAD
    RALEIGH
    NORTH CAROLINA
    27615
    Phone
    (919) 846-4100
    Name of Person for Whose Account the Securities are To Be Sold
    RESTREPO ROBERT P JR
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Fidelity Brokerage Services LLC
    900 Salem Street
    Smithfield � RI � 02917
    10000347158.8815006627406/04/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common09/16/2021CompensationIssuerCheckbox not checked1000009/16/2021Compensation

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    06/04/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert Restrepo

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $ACT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACT

    DatePrice TargetRatingAnalyst
    5/5/2025$39.00Outperform → Mkt Perform
    Keefe Bruyette
    12/6/2023$29.00Neutral
    UBS
    11/13/2023$30.00Neutral → Buy
    BofA Securities
    5/9/2023$25.00 → $27.00Underperform → Neutral
    BofA Securities
    2/8/2023$25.00 → $26.50Mkt Perform → Outperform
    Keefe Bruyette
    1/9/2023$24.50Neutral → Underperform
    Credit Suisse
    9/6/2022$27.00Overweight → Neutral
    JP Morgan
    8/18/2022$25.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $ACT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Genworth Financial Announces Results of Annual Meeting

      Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2025 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2025 Omnibus Incentive Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2025. In addition, stockholders approved an amendment to th

      5/22/25 1:32:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Enact Reports First Quarter 2025 Results

      GAAP Net Income of $166 million, or $1.08 per diluted share Adjusted Operating Income of $169 million, or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion, a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97 RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2025. "We had a strong start to 2025 and continue to make progress against our priorities," stated Rohit Gupta, President a

      4/30/25 4:20:32 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance

    $ACT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Genworth Holdings, Inc. sold $24,449,214 worth of shares (677,121 units at $36.11) (SEC Form 4)

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      6/2/25 4:18:35 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form 4 filed by Chairperson of the Board Addesso Dominic James

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      5/20/25 4:06:58 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form 4 filed by Chairperson of the Board Addesso Dominic James

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      5/19/25 4:14:24 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    SEC Filings

    See more
    • SEC Form 144 filed by Enact Holdings Inc.

      144 - Enact Holdings, Inc. (0001823529) (Subject)

      6/4/25 4:13:15 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Enact Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Enact Holdings, Inc. (0001823529) (Filer)

      5/19/25 4:03:07 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form 10-Q filed by Enact Holdings Inc.

      10-Q - Enact Holdings, Inc. (0001823529) (Filer)

      5/2/25 4:01:56 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Leadership Updates

    Live Leadership Updates

    See more
    • Enact Holdings Set to Join S&P SmallCap 600

      NEW YORK, April 9, 2025 /PRNewswire/ -- Enact Holdings Inc. (NASD: ACT) will replace SolarWinds Corp. (NYSE:SWI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, April 16. Turn/River Capital is acquiring SolarWinds in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector April 16, 2025 S&P SmallCap 600 Addition Enact Holdings ACT Financials April 16, 2025 S&P SmallCap 600 Deletion SolarWinds SWI Information Technology For more information about S&P Dow Jones Indices, please vi

      4/9/25 5:42:00 PM ET
      $ACT
      $SPGI
      $SWI
      Specialty Insurers
      Finance
      Finance: Consumer Services
      Computer Software: Prepackaged Software
    • Enact Announces Changes to its Board of Directors

      RALEIGH, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) today announced that it has appointed H. Elizabeth (Liz) Mitchell as an Independent Director to serve on Enact's Board of Directors, effective March 11, 2025. She has also been appointed as a member of the Audit Committee. In addition, the company announced that Anne G. Waleski has made the decision not to stand for re-election at the 2025 Annual Shareholder Meeting on May 14, 2025. As a result of these actions, Enact's Board will temporarily increase in size from eleven to twelve directors until the company's 2025 Annual Shareholder Meeting. Ms. Mitchell brings deep financial, industry and public

      3/11/25 4:15:00 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Financials

    Live finance-specific insights

    See more
    • Enact Reports First Quarter 2025 Results

      GAAP Net Income of $166 million, or $1.08 per diluted share Adjusted Operating Income of $169 million, or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion, a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97 RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2025. "We had a strong start to 2025 and continue to make progress against our priorities," stated Rohit Gupta, President a

      4/30/25 4:20:32 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Enact Announces 14% Increase to Quarterly Dividend and New $350 Million Share Repurchase Program

      RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) announced that its Board of Directors declared a quarterly dividend of $0.21 per common share, an increase of 14% from the prior quarter's dividend. This dividend will be payable on June 11, 2025, to shareholders of record on May 19, 2025. Additionally, Enact's Board of Directors authorized a new share repurchase program under which the company may purchase up to $350 million of its common stock. The new share repurchase authorization is in addition to the company's current $250 million share repurchase program, of which $6 million remains as of April 25, 2025. "Our increased dividend and new share re

      4/30/25 4:10:00 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $ACT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Enact Holdings downgraded by Keefe Bruyette with a new price target

      Keefe Bruyette downgraded Enact Holdings from Outperform to Mkt Perform and set a new price target of $39.00

      5/5/25 8:29:05 AM ET
      $ACT
      Specialty Insurers
      Finance
    • UBS initiated coverage on Enact Holdings with a new price target

      UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00

      12/6/23 7:20:51 AM ET
      $ACT
      Specialty Insurers
      Finance
    • Enact Holdings upgraded by BofA Securities with a new price target

      BofA Securities upgraded Enact Holdings from Neutral to Buy and set a new price target of $30.00

      11/13/23 7:12:03 AM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

      SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

      2/13/24 4:15:14 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

      SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

      1/24/24 5:00:27 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

      SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

      2/13/23 12:30:19 PM ET
      $ACT
      Specialty Insurers
      Finance